Stakeholder views of ethical guidance regarding prevention and care in HIV vaccine trials.

ABSTRACT:

Background

South Africa is a major hub of HIV prevention trials, with plans for a licensure trial to start in 2015. The appropriate standards of care and of prevention in HIV vaccine trials are complex and debated issues and ethical guidelines offer some direction. However, there has been limited empirical exploration of South African stakeholders' perspectives on ethical guidance related to prevention and care in HIV vaccine trials.

Methods

Site staff, Community Advisory Board members and Research Ethics Committee members involved with current HIV vaccine trials in South Africa were invited to participate in an exploration of their views. A questionnaire listed 10 care and 10 prevention recommendations drawn from two widely available sets of ethical guidelines for biomedica

SUBMITTER: Moorhouse R 

PROVIDER: S-EPMC4104735 | biostudies-literature | 2014 Jun

REPOSITORIES: biostudies-literature